Jim Simons’s Milestone Pharmaceuticals MIST Stock Holding History

Jim Simons’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-129,705	Closed	-$154K	–	3468
2026 Q1	$154K	Buy	+129,705	New	+$227K	﹤0.01%	2960
2023 Q3	–	Sell	-108,766	Closed	-$310K	–	3932
2023 Q2	$310K	Buy	108,766 +16,966	+18%	+$64K	﹤0.01%	3111
2023 Q1	$362K	Buy	91,800 +24,600	+37%	+$89.9K	﹤0.01%	3036
2022 Q4	$266K	Buy	+67,200	New	+$354K	﹤0.01%	3278
2021 Q4	–	Sell	-26,400	Closed	-$151K	–	4106
2021 Q3	$151K	Sell	26,400 -81,154	-75%	-$458K	﹤0.01%	3258
2021 Q2	$592K	Sell	107,554 -108,846	-50%	-$617K	﹤0.01%	2898
2021 Q1	$1.25M	Buy	216,400 +52,400	+32%	+$384K	﹤0.01%	2507
2020 Q4	$1.1M	Buy	164,000 +148,900	+986%	+$997K	﹤0.01%	2457
2020 Q3	$111K	Buy	+15,100	New	+$108K	﹤0.01%	3205
2020 Q2	–	Sell	-10,242	Closed	-$19K	–	3648
2020 Q1	$19K	Buy	+10,242	New	+$177K	﹤0.01%	3375

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Jim Simons's MIST Position: Q2 2026 in Review

Jim Simons sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 129,705 shares — an estimated $154K sold.

Jim Simons first reported a position in MIST in Q1 2020 and held it in 10 quarters. The position peaked at $1.25M in Q1 2021. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Jim Simons reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jim Simons sold 129,705 Milestone Pharmaceuticals shares in Q2 2026, an estimated $154K.
Jim Simons first reported a position in Milestone Pharmaceuticals in Q1 2020 and held it in 10 quarters.
Jim Simons's Milestone Pharmaceuticals position peaked at $1.25M in Q1 2021.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.